Table 3.
Nanoparticles formulated for sepsis management and its preclinical outcomes.
Organ | Nanotherapeutic system | Composition | In-vitro/In-vivo study | Inference | Reference |
---|---|---|---|---|---|
Brain | Micellar nanoparticles | CG3R6-TAT (Antimicrobial peptide) | In-vitro MICs study/In-vivo S. aureus-induced meningitis rabbit model | Nanosystem able to cross BBB and suppressed the growth of Staphylococcus aureus in the brain. | [58] |
Nanoparticles | Amphotericin B, Polybutylcyanoacrylate, Tween-80 | Cryptococcal meningitis mouse model | Nanosystems offered great potential in drug delivery across BBB | [76] | |
Lungs | Nanovesicles | 25-hydroxycholesterol and didodecyldimethlammonium bromide | In-vivo biodistribution in male ICR mice model | Nanosystems can accumulate in the lung tissues and significantly lower the NF-KB and SREBP2 pathways reducing the inflammatory cytokine levels | [59] |
Bio-responsive nanoparticles | Ciprofloxacin and ((2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide) | Acute lung bacterial infection mouse model | Nanoparticle targeting to IMEs and local cues as triggers to deliver therapeutics in on-demand manners is demonstrated | [60] | |
Intestine | Gold nanoparticles | 4,6-diamino-2-pyrimidinethiol and gold | Microflora distribution of Au in mice | Developed nanosystem showed great potential as alternatives to oral antibiotics | [61] |
Polymeric nanoparticles | Ceria, triphenylphosphine and ROS-responsive organic polymer (mPEG-TK-PLGA) | Sepsis-induced AKI mice model | Nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin has favourable potentials in the sepsis-induced AKI therapy | [62] | |
Lipidic nanoparticles | Cathepsin-B, antimicrobial peptide and vitamin C | Immune-compromised septic mice model | Nanosystem offered elimination of MDR bacteria | [63] | |
Skin | Nanoemulsion | Alpha-tocopherol and chitosan oleate | Ex-vivo punch tests on human skin biopsies | Nanosystem enhanced cell production in fibroblast and keratinocytes cell medium and found to help treat topical skin infection | [64] |
Nano-scaffolds | Silk fibroin, chitin and silver nanoparticles | In-vitro antibacterial and antifungal activity evaluation | Fabricated nano-scaffolds offered prominent activity against S. aureus, E. coli and C. albicans | [65] | |
Kidney | Metallic nanoparticles | Iron oxide | In-vivo biodistribution in mice model | Nanoparticles found to be effective against urinary microbes like E. coli | [66] |
Nitric oxide releasing nanoparticles | Chitosan and silane hydrogel | In-vivo mouse infection model | NO-np lead to a reduction in angiogenesis preventing bacterial dissemination from abscesses. NO-np may be useful therapeutics for microbial abscesses | [67] |